SEPN

Septerna Inc

SEPN

Market cap $978M

Overview Fund Trends Analyst Outlook Journalist POV

21.94 USD

--0.38

1.7%

At close Updated Oct 29, 4:00 PM EDT

Pre-market

After hours

21.50

--0.44

2.01%

1 day

-1.7%

5 days

-0.68%

1 month

20.88%

3 months

72.08%

6 months

216.59%

Year to date

2.76%

1 year

9.59%

5 years

2.52%

10 years

2.52%

About: Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.

Employees: 75

Healthcare Biotechnology